Summary

The Global Multiplex Assays Market is currently valued at approximately USD 4.12 billion in 2024 and is anticipated to witness robust growth at a CAGR of 8.80% during the forecast period from 2025 to 2035. Multiplex assays, which enable the simultaneous detection and quantification of multiple biomolecules in a single test, have become indispensable tools in both clinical and research settings. Their ability to deliver high-throughput, cost-effective, and precise analysis is driving adoption across pharmaceutical development, diagnostics, and biomedical research. This expanding demand is further propelled by the rising prevalence of chronic diseases, increasing investment in personalized medicine, and rapid advancements in assay technologies.
The surge in research and development activities, coupled with the growing emphasis on early and accurate disease diagnosis, is fueling the market’s upward trajectory. Multiplex assays facilitate enhanced diagnostic accuracy by allowing concurrent measurement of multiple biomarkers, thus accelerating therapeutic decision-making. Moreover, technological breakthroughs such as flow cytometry and luminescence-based platforms have broadened the application scope, enabling more sensitive and multiplexed analyses. However, challenges including high assay costs and the need for technical expertise may restrain market growth to some extent. Nevertheless, growing healthcare infrastructure in emerging economies and rising awareness about biomarker-driven therapies present lucrative opportunities for market stakeholders.
Geographically, North America dominates the global multiplex assays market owing to its well-established pharmaceutical and biotechnology sectors, substantial R&D expenditure, and presence of key market players. The United States leads this regional growth, driven by innovations in assay technologies and a large pool of clinical trials. Europe holds a significant share, supported by extensive healthcare infrastructure and favorable regulatory frameworks. Meanwhile, the Asia Pacific region is poised to exhibit the fastest growth, spurred by increasing healthcare investments, expanding diagnostics market, and rising prevalence of chronic diseases in countries like China and India. Additionally, government initiatives aimed at bolstering healthcare research and diagnostics are catalyzing the demand in this region, presenting promising growth avenues.
Major market players included in this report are:
• Schlumberger Limited
• Halliburton Company
• BASF SE
• Baker Hughes Company
• Croda International Plc.
• Chevron Phillips Chemical Company
• Trican Well Service Ltd.
• M&D Industries Of Louisiana, Inc.
• Impact Fluid Solutions
• Aubin Group
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• PerkinElmer, Inc.
• BD (Becton, Dickinson and Company)
Global Multiplex Assays Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast Period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Product & Service:
• Consumables
• Instruments
• Software & Services
By Type:
• Nucleic Acid
• Protein
By Technology:
• Flow Cytometry
• Luminescence
By Application:
• R&D
• Diagnosis
By End User:
• Pharma
• Hospitals
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Multiplex Assays Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Multiplex Assays Market Forces Analysis
3.1. Market Forces Shaping The Global Multiplex Assays Market (2024-2035)
3.2. Drivers
3.2.1. Rising prevalence of chronic diseases
3.2.2. Increasing investment in personalized medicine
3.3. Restraints
3.3.1. High assay costs
3.3.2. Need for technical expertise
3.4. Opportunities
3.4.1. Growing healthcare infrastructure in emerging economies
3.4.2. Technological advancements in assay platforms
Chapter 4. Global Multiplex Assays Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Multiplex Assays Market Size & Forecasts by Product & Service 2025-2035
5.1. Market Overview
5.2. Global Multiplex Assays Market Performance - Potential Analysis (2025)
5.3. Consumables
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Instruments
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
5.5. Software & Services
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.5.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Multiplex Assays Market Size & Forecasts by Type 2025–2035
6.1. Market Overview
6.2. Global Multiplex Assays Market Performance - Potential Analysis (2025)
6.3. Nucleic Acid
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Protein
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Multiplex Assays Market Size & Forecasts by Technology 2025–2035
7.1. Market Overview
7.2. Flow Cytometry
7.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.2.2. Market size analysis, by region, 2025-2035
7.3. Luminescence
7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.3.2. Market size analysis, by region, 2025-2035
Chapter 8. Global Multiplex Assays Market Size & Forecasts by Application 2025–2035
8.1. Market Overview
8.2. R&D
8.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.2.2. Market size analysis, by region, 2025-2035
8.3. Diagnosis
8.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
8.3.2. Market size analysis, by region, 2025-2035
Chapter 9. Global Multiplex Assays Market Size & Forecasts by End User 2025–2035
9.1. Market Overview
9.2. Pharma
9.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.2.2. Market size analysis, by region, 2025-2035
9.3. Hospitals
9.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
9.3.2. Market size analysis, by region, 2025-2035
Chapter 10. Global Multiplex Assays Market Size & Forecasts by Region 2025–2035
10.1. Multiplex Assays Market, Regional Market Snapshot
10.2. Top Leading & Emerging Countries
10.3. North America Multiplex Assays Market
10.3.1. U.S. Multiplex Assays Market
10.3.1.1. Product & Service breakdown size & forecasts, 2025-2035
10.3.1.2. Type breakdown size & forecasts, 2025-2035
10.3.1.3. Application breakdown size & forecasts, 2025-2035
10.3.1.4. End User breakdown size & forecasts, 2025-2035
10.3.2. Canada Multiplex Assays Market
10.3.2.1. Product & Service breakdown size & forecasts, 2025-2035
10.3.2.2. Type breakdown size & forecasts, 2025-2035
10.3.2.3. Application breakdown size & forecasts, 2025-2035
10.3.2.4. End User breakdown size & forecasts, 2025-2035
10.4. Europe Multiplex Assays Market
10.4.1. UK Multiplex Assays Market
10.4.1.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.1.2. Type breakdown size & forecasts, 2025-2035
10.4.1.3. Application breakdown size & forecasts, 2025-2035
10.4.1.4. End User breakdown size & forecasts, 2025-2035
10.4.2. Germany Multiplex Assays Market
10.4.2.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.2.2. Type breakdown size & forecasts, 2025-2035
10.4.2.3. Application breakdown size & forecasts, 2025-2035
10.4.2.4. End User breakdown size & forecasts, 2025-2035
10.4.3. France Multiplex Assays Market
10.4.3.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.3.2. Type breakdown size & forecasts, 2025-2035
10.4.3.3. Application breakdown size & forecasts, 2025-2035
10.4.3.4. End User breakdown size & forecasts, 2025-2035
10.4.4. Spain Multiplex Assays Market
10.4.4.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.4.2. Type breakdown size & forecasts, 2025-2035
10.4.4.3. Application breakdown size & forecasts, 2025-2035
10.4.4.4. End User breakdown size & forecasts, 2025-2035
10.4.5. Italy Multiplex Assays Market
10.4.5.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.5.2. Type breakdown size & forecasts, 2025-2035
10.4.5.3. Application breakdown size & forecasts, 2025-2035
10.4.5.4. End User breakdown size & forecasts, 2025-2035
10.4.6. Rest of Europe Multiplex Assays Market
10.4.6.1. Product & Service breakdown size & forecasts, 2025-2035
10.4.6.2. Type breakdown size & forecasts, 2025-2035
10.4.6.3. Application breakdown size & forecasts, 2025-2035
10.4.6.4. End User breakdown size & forecasts, 2025-2035
10.5. Asia Pacific Multiplex Assays Market
10.5.1. China Multiplex Assays Market
10.5.1.1. Product & Service breakdown size & forecasts, 2025-2035
10.5.1.2. Type breakdown size & forecasts, 2025-2035
10.5.1.3. Application breakdown size & forecasts, 2025-2035
10.5.1.4. End User breakdown size & forecasts, 2025-2035
10.5.2. Japan Multiplex Assays Market
10.5.2.1. Product & Service breakdown size & forecasts, 2025-2035
10.5.2.2. Type breakdown size & forecasts, 2025-2035
10.5.2.3. Application breakdown size & forecasts, 2025-2035
10.5.2.4. End User breakdown size & forecasts, 2025-2035
10.5.3. India Multiplex Assays Market
10.5.3.1. Product & Service breakdown size & forecasts, 2025-2035
10.5.3.2. Type breakdown size & forecasts, 2025-2035
10.5.3.3. Application breakdown size & forecasts, 2025-2035
10.5.3.4. End User breakdown size & forecasts, 2025-2035
10.5.4. Australia Multiplex Assays Market
10.5.4.1. Product & Service breakdown size & forecasts, 2025-2035
10.5.4.2. Type breakdown size & forecasts, 2025-2035
10.5.4.3. Application breakdown size & forecasts, 2025-2035
10.5.4.4. End User breakdown size & forecasts, 2025-2035
10.5.5. Rest of Asia Pacific Multiplex Assays Market
10.5.5.1. Product & Service breakdown size & forecasts, 2025-2035
10.5.5.2. Type breakdown size & forecasts, 2025-2035
10.5.5.3. Application breakdown size & forecasts, 2025-2035
10.5.5.4. End User breakdown size & forecasts, 2025-2035
10.6. Middle East & Africa Multiplex Assays Market
10.6.1. South Africa Multiplex Assays Market
10.6.1.1. Product & Service breakdown size & forecasts, 2025-2035
10.6.1.2. Type breakdown size & forecasts, 2025-2035
10.6.1.3. Application breakdown size & forecasts, 2025-2035
10.6.1.4. End User breakdown size & forecasts, 2025-2035
10.6.2. Rest of Middle East & Africa Multiplex Assays Market
10.6.2.1. Product & Service breakdown size & forecasts, 2025-2035
10.6.2.2. Type breakdown size & forecasts, 2025-2035
10.6.2.3. Application breakdown size & forecasts, 2025-2035
10.6.2.4. End User breakdown size & forecasts, 2025-2035
Chapter 11. Competitive Intelligence
11.1. Thermo Fisher Scientific Inc.
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.3. Recent Developments
11.1.4. Strategic Initiatives
11.2. Sigma-Aldrich Corporation
11.3. Bio-Rad Laboratories, Inc.
11.4. Merck KGaA
11.5. Agilent Technologies, Inc.
11.6. Luminex Corporation
11.7. Qiagen N.V.
11.8. PerkinElmer, Inc.
11.9. Other Key Players